RxDoctor Payments Data

George Cioffi, APRN

Psychiatric/Mental Health · Hollywood, FLNPI 1578529343

Payments from drug & device makers

$3,357in general payments, 2019–2025

Across 155 payments — averaging $21.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Lundbeck LLC$773
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$452
  • Otsuka America Pharmaceutical, Inc.$259
  • Almatica Pharma LLC$235
  • Sunovion Pharmaceuticals Inc.$190
  • plus $125 from 3 others

What the payments were for

  • Food & beverage$3,26397%
  • Education$943%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,357 in reported general payments places this provider in the 80th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida

Medicare billing

Part B allowed, 2024
$51,842
Medicare patients
139
Services billed
683

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole100$180,167
TrintellixVortioxetine Hydrobromide86$50,841
VraylarCariprazine Hcl33$47,827
Invega SustennaPaliperidone Palmitate14$47,783
Abilify MaintenaAripiprazole14$37,403
CaplytaLumateperone Tosylate12$20,408
NamzaricMemantine Hcl/Donepezil Hcl17$14,403
BelsomraSuvorexant29$11,911
Quetiapine Fumarate ErQuetiapine Fumarate96$11,900
Lurasidone Hcl30$11,044
Aripiprazole147$7,154
Bupropion XlBupropion Hcl364$6,994
Duloxetine Hcl272$5,824
Clonazepam739$5,477
Trazodone Hcl473$5,331

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$259$217,570114 claims
AbbVieVraylar, Namzaric$1,323$62,23050 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$452$20,40812 claims
Almatica Pharma LLCSertraline Hcl$235$1,449169 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,096 psychiatric/mental health providers in Florida.

Other psychiatric/mental health in Hollywood

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →